Helen Sabzevari
Chief Executive Officer bij PRECIGEN, INC.
Vermogen: 2 M $ op 29-02-2024
Profiel
Founder of Compass Therapeutics LLC, Helen Sabzevari currently is President, Chief Executive Officer & Director at Precigen, Inc. and President at PGEN Therapeutics, Inc. (a subsidiary of Precigen, Inc.).
She is also on the board of Kinnate Biopharma, Inc.
In the past Dr. Sabzevari was Senior Vice President-Health Therapeutics at Precigen, Inc., Chief Scientific Officer for Compass Therapeutics LLC and Global Head-Immunotherapy, Oncology & Research at EMD Serono, Inc.
Helen Sabzevari received a doctorate from The Scripps Research Institute.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
PRECIGEN INC
0.63% | 25-08-2023 | 1 560 004 ( 0.63% ) | 2 M $ | 29-02-2024 |
KINNATE BIOPHARMA, INC.
-.--% | 12-06-2023 | 0 ( -.--% ) | - $ | 29-02-2024 |
Actieve functies van Helen Sabzevari
Bedrijven | Functie | Begin |
---|---|---|
PRECIGEN, INC. | Chief Executive Officer | 01-01-2020 |
KINNATE BIOPHARMA INC. | Director/Board Member | 24-06-2021 |
PGEN Therapeutics, Inc.
PGEN Therapeutics, Inc. BiotechnologyHealth Technology Part of Precigen, Inc., PGEN Therapeutics, Inc. develops gene and cellular therapies. The private company is based in Henrico, MD. | President | 01-11-2017 |
Eerdere bekende functies van Helen Sabzevari
Bedrijven | Functie | Einde |
---|---|---|
PRECIGEN, INC. | Corporate Officer/Principal | 01-11-2017 |
Compass Therapeutics LLC
Compass Therapeutics LLC BiotechnologyHealth Technology Compass Therapeutics LLC operates as a healthcare industry focusing on biotechnology. It offers drug discovery, development, biologics, oncology and immuno-oncology. The company was founded by Errik B. Anderson and Thomas J. Schuetz in 2014 and is headquartered in Cambridge, MA. | Founder | 01-01-2017 |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Chief Tech/Sci/R&D Officer | 01-01-2014 |
Opleiding van Helen Sabzevari
The Scripps Research Institute | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
PRECIGEN, INC. | Health Technology |
KINNATE BIOPHARMA INC. | Health Technology |
Bedrijven in privébezit | 3 |
---|---|
Compass Therapeutics LLC
Compass Therapeutics LLC BiotechnologyHealth Technology Compass Therapeutics LLC operates as a healthcare industry focusing on biotechnology. It offers drug discovery, development, biologics, oncology and immuno-oncology. The company was founded by Errik B. Anderson and Thomas J. Schuetz in 2014 and is headquartered in Cambridge, MA. | Health Technology |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Health Technology |
PGEN Therapeutics, Inc.
PGEN Therapeutics, Inc. BiotechnologyHealth Technology Part of Precigen, Inc., PGEN Therapeutics, Inc. develops gene and cellular therapies. The private company is based in Henrico, MD. | Health Technology |